COVID-19 patients show varying severity of the disease ranging from asymptomatic to requiring intensive care. Although a number of monoclonal antibodies against SARS-CoV-2 have been identified, we sti
These are the processed BCR repertoire and transcriptomics data described in Kim & Zhou et al., Nature, 2022. The raw sequencing data new to this study are available on SRA under BioProject PRJNA77793
Inflammatory (B220+ CD19+ CD44+ CD11c+ Tbet-AmCyanhi) B cells were sorted from female Tbet-AmCyan reporter mice at day 8, 10, and 15 post infection with LCMV-Armstrong. RNA-seq was employed to assess
PBMCCD19+ (B cells) activatedCPG ODN2006 24h For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy